• Fayssal M Farahat, Norah T Faqih, Razan S Alharbi, Raheed I Mudarris, Sahl A Alshaikh, and Hatim M Al-Jifree.
• From the Infection Prevention and Control Department (Farahat), King Abdulaziz Medical City, Ministry of National Guard Health Affairs; from King Abdullah International Medical Research Center (Farahat, Al-Jifree); from the College of Medicine (Farahat, Alshaikh, Al-Jifree), King Saud bin Abdulaziz University for Health Sciences, Jeddah; from the College of Medicine (Faqih), Umm Al-Qura University, Makkah; from the College of Medicine (Alharbi, Mudarris), Ibn Sina National College; and from the Department of Oncology (Al-Jifree), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Kingdom of Saudi Arabia.
• Saudi Med J. 2021 Mar 1; 42 (3): 338-341.

ObjectivesTo investigate the epidemiological characteristics of cervical cancer cases reported at a tertiary care teaching hospital in western Saudi Arabia.MethodsA retrospective chart review was conducted on medical records of patients diagnosed with cervical cancer at King Abdulaziz Medical City, Jeddah, Saudi Arabia. Data were collected on demographic characteristics, histological types and stage, treatment modalities, and disease outcomes.ResultsCervical cancer was diagnosed among 89 patients from 2002 to 2018. History of pap smear was reported among 31 cases (34.8%). Squamous cell carcinoma was the most common reported histopathological subtype. Almost one third (29.2%) of the patients were at stage III or IV at the time of diagnosis. The most frequent treatment regimen was combined radio/chemotherapy. Kaplan-Meier analysis showed an overall survival rate of 81.5%.ConclusionThe lack of an effective screening program for cervical cancer increases the likelihood of a late diagnosis and higher rates of complications and mortality. Public health programs should focus on cancer screening, screening, and reporting HPV infections, and supporting HPV vaccination activities.Copyright: © Saudi Medical Journal.

30 keywords...

hide…